Results 1 to 10 of about 648,642 (402)

Review on the simultaneous determination of total prostate-specific antigen and free prostate-specific antigen [PDF]

open access: greenThe Prostate, 2004
The total prostate-specific antigen (t-PSA) in serum measured by PSA assays represents the sum of free (f-PSA) and PSA complexed with alpha 1-antichymotrypsin. The f-PSA/t-PSA (F/T) ratio in prostate cancer (PCA) patients is lower than in patients suffering from benign prostatic hyperplasia (BPH).
C.M. G. Thomas   +5 more
core   +11 more sources

Prostate specific antigen [PDF]

open access: yesAustralian family physician, 2011
The use of PSA as a screening test for prostate cancer remains controversial because no double blind, randomised controlled trial has shown that early detection reduces mortality.1,2 Despite this controversy, PSA provides valuable information for the ...
Brett, Tom
core   +5 more sources

Prostate Specific Antigen: A review [PDF]

open access: bronzeActa Oncologica, 1991
Despite its identification in the 1970s, prostate specific antigen (PSA) has only recently gained widespread utility. In this review, we will describe significant aspects of the biochemistry of PSA, immunohistochemical applications, the effect of prostatic manipulation on the serum level of this analyte, and other considerations in the determination of
M K Brawer
openalex   +4 more sources

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer [PDF]

open access: yesProstate International, 2013
Racial differences exist in the incidence of prostate cancer (PCa). Although many studies have looked at the performance of prostate-specific antigen (PSA) and PSA density (PSAD) in the detection of PCa, only a few have looked at it in relation to ...
Ahmad Anies Shahab   +5 more
doaj   +6 more sources

The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity [PDF]

open access: greenClinical Chemistry and Laboratory Medicine, 1997
This study describes the value of using the fraction of free prostate-specific antigen as a further marker in the early detection of prostate cancer. This newly introduced marker is compared to the usual battery of age-dependent total prostate-specific antigen, prostate-specific antigen density (microg/l x g tissue) and prostate-specific antigen ...
Mira Barak   +6 more
openalex   +4 more sources

Pretreatment tumor volume estimation based on total serum psa in patients with localized prostate cancer [PDF]

open access: yesClinics, 2008
OBJECTIVES: To establish a formula that estimates tumor volume in localized prostate cancer based on serum prostate specific antigen levels. One of the main prognostic variables in localized prostate cancer is tumor volume, which can be precisely defined
Raphael Barroso Kato   +5 more
doaj   +5 more sources

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men

open access: yesAsian Journal of Andrology, 2017
We investigated the performance characteristics of prostate-specific antigen (PSA) and PSA density (PSAD) in Chinese men. All Chinese men who underwent transrectal ultrasound-guided prostate biopsy (TRUS-PB) from year 2000 to 2013 were included.
Jeremy YC Teoh   +8 more
doaj   +4 more sources

Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0–25.0 ng ml-1 in Western China

open access: yesAsian Journal of Andrology, 2022
The goal of this study was to investigate the clinical application of free/total prostate-specific antigen (F/T PSA) ratio, considering the new broad serum total PSA (T-PSA) “gray zone” of 2.0–25.0 ng ml−1 in differential diagnosis of prostate cancer ...
Xue-Dan Gao   +7 more
doaj   +1 more source

Mathematical Modeling Insights into Improving CAR T cell Therapy for Solid Tumors: Antigen Heterogeneity and Bystander Effects [PDF]

open access: yesnpj Systems Biology and Applications, 10(1), 105 (2024), 2023
As an adoptive cellular therapy, Chimeric Antigen Receptor T-cell (CAR T-cell) therapy has shown remarkable success in hematological malignancies, but only limited efficacy against solid tumors. Compared with blood cancers, solid tumors present a unique set of challenges that ultimately neutralize the function of CAR T-cells.
arxiv   +1 more source

Body mass index in relation to prostate-specific antigen-related parameters

open access: yesBMC Urology, 2021
Background Only a few previous studies conducted to assess the association between body mass index (BMI) and prostate-specific antigen (PSA) related parameters have taken prostate volume (PV) and blood volume (BV) into consideration.
Dandan Lin   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy